Background/Aims: Turner syndrome (TS) is associated with increased mortality due to cardiovascular disease and a dramatically higher rate of aortic dissection. The recognition and treatment of hypertension in this population is critical. We sought to assess the ability to detect blood pressure (BP) abnormalities comparing ambulatory blood pressure monitoring (ABPM) with conventional BP measurement methods. We hypothesized that ABPM would improve detection of hypertension and alter management strategies. Methods: Twenty-three girls with TS underwent BP measurements using an automated oscillometric method and a manual mercury sphygmomanometer. Twenty-four-hour ABPM was performed (Spacelabs 90217, Issaquah, Wash., USA). BP values were compared to normative data based on height and sex for ABPM, and for age, height and sex for automated oscillometric and manual measurements. Results: Five (22%) subjects were found to have ambulatory hypertension (3 of these with severe hypertension). Three subjects had prehypertension using ABPM measurements. Only 1 of the 5 patients with ambulatory hypertension was categorized as hypertensive using manual BP measurements. Twelve subjects (52%) had nocturnal hypertension. ABPM data led to a change in medical management of hypertensive patients with initiation of antihypertensive therapy. Conclusions: ABPM is advantageous in TS, as it improves detection of hypertension, identifies those with non-dipping BP patterns, and changes medical management of patients.

1.
Stochholm K, Juul S, Juel K, et al: Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab 2006;91:3897-3902.
[PubMed]
2.
Schoemaker MJ, Swerdlow AJ, Higgins CD, et al, United Kingdom Clinical Cytogenetics Group: Mortality in women with Turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab 2008;93:4735-4742.
[PubMed]
3.
Sybert VP: Cardiovascular malformations and complications in Turner syndrome. Pediatrics 1998;101:E11.
[PubMed]
4.
Ho VB, Bakalov VK, Cooley M, et al: Major vascular anomalies in Turner syndrome: prevalence and magnetic resonance angiographic features. Circulation 2004;110:1694-1700.
[PubMed]
5.
Gravholt CH, Landin-Wilhelmsen K, Stochholm K, et al: Clinical and epidemiological description of aortic dissection in Turner's syndrome. Cardiol Young 2006;16:430-436.
[PubMed]
6.
Carlson M, Silberbach M: Dissection of the aorta in Turner syndrome: two cases and review of 85 cases in the literature. J Med Genet 2007;44:745-749.
[PubMed]
7.
Ostberg J, Donald AE, Halcox JP, et al: Vasculopathy in Turner syndrome: arterial dilatation and intimal thickening without endothelial dysfunction. J Clin Endocrinol Metab 2005;90:5161-5166.
[PubMed]
8.
Mortensen K, Hjerrild BE, Stochholm K, et al: Dilation of the ascending aorta in Turner syndrome - a prospective cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2011;13:24.
[PubMed]
9.
Nathwani NC, Unwin R, Brook CG, Hindmarsh PC: Blood pressure and Turner syndrome. Clin Endocrinol 2000;52:363-370.
[PubMed]
10.
White WB: Ambulatory blood pressure as a predictor of target organ disease and outcome in the hypertensive patient. Blood Press Monit 1999;4:181-184.
[PubMed]
11.
Ohkubo T, Imai Y, Tsuji I, et al: Relation between nocturnal decline in blood pressure and mortality. The Ohasama Study. Am J Hypertens 1997;10:1201-1207.
[PubMed]
12.
Schmidt PJ, Cardoso GM, Ross JL, et al: Shyness, social anxiety, and impaired self-esteem in Turner syndrome and premature ovarian failure. JAMA 2006;295:1374-1376.
[PubMed]
13.
Yetman RJ, Portman RJ: Technical aspects of blood pressure measurement in pediatric patients. Blood Press Monit 1999;4:155-159.
[PubMed]
14.
Sorof JM, Portman RJ: White coat hypertension in children with elevated casual blood pressure. J Pediatr 2000;137:493-497.
[PubMed]
15.
Floriańczyk T, Werner B: Usefulness of ambulatory blood pressure monitoring in diagnosis of arterial hypertension in children and adolescents. Kardiol Pol 2008;66:12-17.
[PubMed]
16.
Matsuoka S, Kawamura K, Honda M, Awazu M: White coat effect and white coat hypertension in pediatric patients. Pediatr Nephrol 2002;17:950-953.
[PubMed]
17.
Belsha CW, Wells TG, McNiece KL, et al: Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension. Am J Hypertens 1998;11:410-417.
[PubMed]
18.
Sorof JM, Cardwell G, Franco K, Portman RJ: Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension 2002;39:903-908.
[PubMed]
19.
McNiece KL, Gupta-Malhotra M, Samuels J, et al, National High Blood Pressure Education Program Working Group: Left ventricular hypertrophy in hypertensive adolescents: analysis of risk by 2004 National High Blood Pressure Education Program Working Group staging criteria. Hypertension 2007;50:392-395.
[PubMed]
20.
Khattar RS, Acharya DU, Kinsey C, et al: Longitudinal association of ambulatory pulse pressure with left ventricular mass and vascular hypertrophy in essential hypertension. J Hypertens 1997;15:737-743.
[PubMed]
21.
Bondy CA, Turner Syndrome Study Group: Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab 2007;92:10-25.
[PubMed]
22.
Urbina E, Alpert B, Flynn, et al, American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee: Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Hypertension 2008;52:433-451.
[PubMed]
23.
Hammer LD, Kraemer HC, Wilson DM, et al: Standardized percentile curves of body mass index for children and adolescents. Am J Dis Child 1991;145:259-263.
[PubMed]
24.
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents: The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114(suppl 2): 555-576.
[PubMed]
25.
Wühl E, Witte K, Soergel M, Mehls O, Schaefer F; German Working Group on Pediatric Hypertension: Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 2002;20:1995-2007.
[PubMed]
26.
Mortensen KH, Hansen KW, Erlandsen M, et al: Ambulatory arterial stiffness index in Turner syndrome: the impact of sex hormone replacement therapy. Horm Res 2009;72:184-189.
[PubMed]
27.
Eklund M, Kotilainen J, Evälahti M, Waltimo-Sirén J: Cephalometric analysis of pharyngeal airway space dimensions in Turner syndrome. Eur J Orthod 2012;34:219-225.
[PubMed]
28.
Wolf J, Hering D, Narkiewicz K: Non-dipping pattern of hypertension and obstructive sleep apnea syndrome. Hypertens Res 2010;33:867-871.
[PubMed]
29.
Giordano R, Forno D, Lanfranco F, et al: Metabolic and cardiovascular outcomes in a group of adult patients with Turner syndrome under hormonal replacement therapy. Eur J Endocrinol 2011;164:819-826.
[PubMed]
30.
Hansen TW, Li Y, Boggia J, et al: Predictive role of the nighttime blood pressure. Hypertension 2011;57:3-10.
[PubMed]
31.
Vasunta RL, Kesäniemi YA, Ylitalo A, Ukkola O: Non-dipping pattern and carotid atherosclerosis in a middle-aged population: OPERA Study. Am J Hypertens 2012;25:60-66.
[PubMed]
32.
Hermida RC, et al: Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int 2010;27:1629-1651.
[PubMed]
33.
Hermida RC, Smolensky MH, Ayala DE, Portaluppi F: 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Chronobiol Int 2013;30:355-410.
[PubMed]
34.
Shores J, Berger KR, Murphy EA, et al: Progression of aortic dilatation and the benefit of long-term β-adrenergic blockade in Marfan's syndrome. N Engl J Med 1994;330:1335-1341.
[PubMed]
35.
Habashi JP, Judge DP, Holm TM, et al: Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006;312:117-121.
[PubMed]
36.
Hiratzka L, Bakris GL, Beckman JA, et al: 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease. Circulation 2010;121:266-369.
[PubMed]
37.
Ostberg JE, Brookes JA, McCarthy C, et al: A comparison of echocardiography and magnetic resonance imaging in cardiovascular screening of adults with Turner syndrome. J Clin Endocrinol Metab 2004;89:5966-5971.
[PubMed]
You do not currently have access to this content.